

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * tricarboxylic acid cycle (GO:0006099) | 7.84031874 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.40369940 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 6.68157837 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.68157837 |
| 5 | oxidative phosphorylation (GO:0006119) | 6.38972933 |
| 6 | * NADH metabolic process (GO:0006734) | 5.82577539 |
| 7 | respiratory electron transport chain (GO:0022904) | 5.61198514 |
| 8 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.51953988 |
| 9 | electron transport chain (GO:0022900) | 5.47082010 |
| 10 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.46714810 |
| 11 | sarcomere organization (GO:0045214) | 5.37195853 |
| 12 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.23864806 |
| 13 | regulation of coenzyme metabolic process (GO:0051196) | 5.10743367 |
| 14 | regulation of cofactor metabolic process (GO:0051193) | 5.10743367 |
| 15 | succinate metabolic process (GO:0006105) | 4.79382405 |
| 16 | muscle filament sliding (GO:0030049) | 4.63630466 |
| 17 | actin-myosin filament sliding (GO:0033275) | 4.63630466 |
| 18 | formation of translation preinitiation complex (GO:0001731) | 4.62311917 |
| 19 | cardiac myofibril assembly (GO:0055003) | 4.52696776 |
| 20 | cullin deneddylation (GO:0010388) | 4.43056617 |
| 21 | ATP biosynthetic process (GO:0006754) | 4.23941888 |
| 22 | protein deneddylation (GO:0000338) | 4.16105959 |
| 23 | regulation of translational fidelity (GO:0006450) | 4.04327601 |
| 24 | cardiac muscle contraction (GO:0060048) | 4.04295772 |
| 25 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.99261955 |
| 26 | myofibril assembly (GO:0030239) | 3.97400385 |
| 27 | proline biosynthetic process (GO:0006561) | 3.95995979 |
| 28 | regulation of mitochondrial translation (GO:0070129) | 3.95533803 |
| 29 | protein complex biogenesis (GO:0070271) | 3.94893106 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.92113937 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.92113937 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 3.92113937 |
| 33 | establishment of integrated proviral latency (GO:0075713) | 3.91316176 |
| 34 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.86188843 |
| 35 | heart contraction (GO:0060047) | 3.85725219 |
| 36 | heart process (GO:0003015) | 3.85725219 |
| 37 | ribosomal small subunit biogenesis (GO:0042274) | 3.83873993 |
| 38 | protein maturation by protein folding (GO:0022417) | 3.80812792 |
| 39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.80557333 |
| 40 | aerobic respiration (GO:0009060) | 3.78007769 |
| 41 | DNA unwinding involved in DNA replication (GO:0006268) | 3.77774605 |
| 42 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.76536103 |
| 43 | DNA strand elongation (GO:0022616) | 3.74286265 |
| 44 | quinone biosynthetic process (GO:1901663) | 3.73886480 |
| 45 | ubiquinone biosynthetic process (GO:0006744) | 3.73886480 |
| 46 | regulation of sulfur metabolic process (GO:0042762) | 3.73066564 |
| 47 | * oxaloacetate metabolic process (GO:0006107) | 3.72752013 |
| 48 | actin-mediated cell contraction (GO:0070252) | 3.68872121 |
| 49 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.68533320 |
| 50 | COPI coating of Golgi vesicle (GO:0048205) | 3.68426913 |
| 51 | Golgi transport vesicle coating (GO:0048200) | 3.68426913 |
| 52 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.66746404 |
| 53 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.66746404 |
| 54 | ribosomal small subunit assembly (GO:0000028) | 3.66035712 |
| 55 | ribosome assembly (GO:0042255) | 3.63023954 |
| 56 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.59526302 |
| 57 | ribosomal large subunit biogenesis (GO:0042273) | 3.58350926 |
| 58 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.55322364 |
| 59 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.54854222 |
| 60 | inner mitochondrial membrane organization (GO:0007007) | 3.54638042 |
| 61 | maturation of SSU-rRNA (GO:0030490) | 3.50707363 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.49868607 |
| 63 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.48854076 |
| 64 | IMP biosynthetic process (GO:0006188) | 3.47926598 |
| 65 | cardiac muscle cell development (GO:0055013) | 3.47924880 |
| 66 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.46635466 |
| 67 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.44950498 |
| 68 | purine nucleobase biosynthetic process (GO:0009113) | 3.44230544 |
| 69 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.42427966 |
| 70 | regulation of relaxation of muscle (GO:1901077) | 3.39875635 |
| 71 | nucleobase biosynthetic process (GO:0046112) | 3.39795488 |
| 72 | tRNA aminoacylation for protein translation (GO:0006418) | 3.39513690 |
| 73 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.37139164 |
| 74 | protein targeting to mitochondrion (GO:0006626) | 3.36368726 |
| 75 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34947792 |
| 76 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.34758276 |
| 77 | IMP metabolic process (GO:0046040) | 3.34181111 |
| 78 | proteasome assembly (GO:0043248) | 3.34148627 |
| 79 | galactose catabolic process (GO:0019388) | 3.33557553 |
| 80 | tRNA aminoacylation (GO:0043039) | 3.32087940 |
| 81 | amino acid activation (GO:0043038) | 3.32087940 |
| 82 | ribosome biogenesis (GO:0042254) | 3.31560450 |
| 83 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.30929335 |
| 84 | striated muscle contraction (GO:0006941) | 3.29971360 |
| 85 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.29493496 |
| 86 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.29375203 |
| 87 | actomyosin structure organization (GO:0031032) | 3.27740149 |
| 88 | regulation of skeletal muscle contraction (GO:0014819) | 3.25297809 |
| 89 | ubiquinone metabolic process (GO:0006743) | 3.24687150 |
| 90 | hydrogen ion transmembrane transport (GO:1902600) | 3.23576770 |
| 91 | viral transcription (GO:0019083) | 3.23119096 |
| 92 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.22583280 |
| 93 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 3.17186067 |
| 94 | cardiac cell development (GO:0055006) | 3.16906251 |
| 95 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.16798150 |
| 96 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.16798150 |
| 97 | establishment of viral latency (GO:0019043) | 3.15973271 |
| 98 | chaperone-mediated protein transport (GO:0072321) | 3.15837369 |
| 99 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.15266818 |
| 100 | negative regulation of ligase activity (GO:0051352) | 3.14594763 |
| 101 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.14594763 |
| 102 | regulation of actin filament-based movement (GO:1903115) | 3.13393214 |
| 103 | cellular respiration (GO:0045333) | 3.13258656 |
| 104 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.12795857 |
| 105 | cardiac muscle hypertrophy (GO:0003300) | 3.12417427 |
| 106 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.11239693 |
| 107 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.10186106 |
| 108 | translational termination (GO:0006415) | 3.10124149 |
| 109 | regulation of cellular respiration (GO:0043457) | 3.09612987 |
| 110 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.09446572 |
| 111 | translation (GO:0006412) | 3.09272163 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.08663213 |
| 113 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.07959903 |
| 114 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.06204642 |
| 115 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.06120056 |
| 116 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.04895667 |
| 117 | establishment of protein localization to mitochondrion (GO:0072655) | 3.04654408 |
| 118 | translational elongation (GO:0006414) | 3.04624281 |
| 119 | * gluconeogenesis (GO:0006094) | 3.04542117 |
| 120 | translational initiation (GO:0006413) | 3.04473963 |
| 121 | cellular component biogenesis (GO:0044085) | 3.03561715 |
| 122 | L-serine metabolic process (GO:0006563) | 3.03218531 |
| 123 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.01188227 |
| 124 | spliceosomal snRNP assembly (GO:0000387) | 2.99972674 |
| 125 | DNA replication initiation (GO:0006270) | 2.99740247 |
| 126 | positive regulation of ligase activity (GO:0051351) | 2.99669408 |
| 127 | cotranslational protein targeting to membrane (GO:0006613) | 2.99518957 |
| 128 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.99310294 |
| 129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.99310294 |
| 130 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.99239432 |
| 131 | protein targeting to ER (GO:0045047) | 2.99184772 |
| 132 | * monosaccharide biosynthetic process (GO:0046364) | 2.98117650 |
| 133 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.97848698 |
| 134 | mitochondrial transport (GO:0006839) | 2.97307035 |
| 135 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.96965031 |
| 136 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.96965031 |
| 137 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.96965031 |
| 138 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.94102082 |
| 139 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.94102082 |
| 140 | protein localization to mitochondrion (GO:0070585) | 2.93953054 |
| 141 | striated muscle hypertrophy (GO:0014897) | 2.93840840 |
| 142 | carnitine shuttle (GO:0006853) | 2.93331813 |
| 143 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.93200724 |
| 144 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.93135328 |
| 145 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.92992277 |
| 146 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.92899048 |
| 147 | * hexose biosynthetic process (GO:0019319) | 2.92207220 |
| 148 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90078199 |
| 149 | protein localization to endoplasmic reticulum (GO:0070972) | 2.88978059 |
| 150 | regulation of translational termination (GO:0006449) | 2.86208277 |
| 151 | histone arginine methylation (GO:0034969) | 2.85652195 |
| 152 | regulation of ligase activity (GO:0051340) | 2.83397919 |
| 153 | pseudouridine synthesis (GO:0001522) | 2.82050950 |
| 154 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.80902547 |
| 155 | glycolytic process (GO:0006096) | 2.78772251 |
| 156 | transcription from mitochondrial promoter (GO:0006390) | 2.78161991 |
| 157 | rRNA processing (GO:0006364) | 2.77525174 |
| 158 | AMP metabolic process (GO:0046033) | 2.76895154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.83063716 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.52983615 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.98132454 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92165696 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.80848321 |
| 6 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.75138453 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.65531951 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.59039779 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.58821654 |
| 10 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.57433273 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.41669126 |
| 12 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.05813250 |
| 13 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.01268819 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.00245594 |
| 15 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.77041453 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.66020295 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.61196359 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.59736771 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.52430098 |
| 20 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.36999221 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.35553636 |
| 22 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.31225906 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.22703841 |
| 24 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.19770206 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.19732173 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.19423508 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18392281 |
| 28 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.15952400 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.09629070 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00165797 |
| 31 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97680501 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.88686450 |
| 33 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.87103946 |
| 34 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.86601704 |
| 35 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85085602 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.85006446 |
| 37 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.81691150 |
| 38 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.78449040 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.77746657 |
| 40 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72817957 |
| 41 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.65467356 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.65263413 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62013539 |
| 44 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.60361989 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57304150 |
| 46 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.56711559 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56226030 |
| 48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.51113050 |
| 49 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50251046 |
| 50 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48628632 |
| 51 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.43103291 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41821112 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.40944121 |
| 54 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39935793 |
| 55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.35935245 |
| 56 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29463464 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28004584 |
| 58 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.27746868 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26270856 |
| 60 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25156352 |
| 61 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24676296 |
| 62 | MYC_22102868_ChIP-Seq_BL_Human | 1.24137655 |
| 63 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24069153 |
| 64 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.23232696 |
| 65 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.22318944 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21046699 |
| 67 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.20455006 |
| 68 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.19312888 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16246993 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15129128 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14059343 |
| 72 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.13222676 |
| 73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.12639610 |
| 74 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11859811 |
| 75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09756642 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09531653 |
| 77 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.09447407 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09271192 |
| 79 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09088890 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08378379 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.08283278 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.07683156 |
| 83 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06002923 |
| 84 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.05981940 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03527859 |
| 86 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02074548 |
| 87 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01948383 |
| 88 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01061940 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00757165 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00432986 |
| 91 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.00061307 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99797119 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99479707 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98979173 |
| 95 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98807763 |
| 96 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98265696 |
| 97 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96984769 |
| 98 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95674020 |
| 99 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.95060371 |
| 100 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.93506543 |
| 101 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.93121918 |
| 102 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.92403710 |
| 103 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91993939 |
| 104 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90981904 |
| 105 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90665645 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90570729 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90383968 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87773763 |
| 109 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87480544 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.87365516 |
| 111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85475222 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85269909 |
| 113 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84399227 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.84236456 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84083552 |
| 116 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.82819821 |
| 117 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82393329 |
| 118 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.81501054 |
| 119 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81396837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.87475082 |
| 2 | MP0003646_muscle_fatigue | 5.47214644 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.80692189 |
| 4 | MP0000751_myopathy | 4.53035659 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.02625499 |
| 6 | MP0000749_muscle_degeneration | 3.76882970 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.61923540 |
| 8 | MP0005451_abnormal_body_composition | 3.31072879 |
| 9 | MP0005330_cardiomyopathy | 3.22053845 |
| 10 | MP0006036_abnormal_mitochondrial_physio | 3.15198328 |
| 11 | MP0002972_abnormal_cardiac_muscle | 2.57002034 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.45477613 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.41278649 |
| 14 | MP0006035_abnormal_mitochondrial_morpho | 2.37579444 |
| 15 | MP0002269_muscular_atrophy | 2.35752940 |
| 16 | MP0005620_abnormal_muscle_contractility | 2.29754362 |
| 17 | MP0003221_abnormal_cardiomyocyte_apopto | 2.22957779 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.22349640 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.19710621 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.19651432 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 2.14254180 |
| 22 | MP0005385_cardiovascular_system_phenoty | 2.14254180 |
| 23 | MP0008007_abnormal_cellular_replicative | 2.13922216 |
| 24 | MP0004233_abnormal_muscle_weight | 2.13706946 |
| 25 | MP0002106_abnormal_muscle_physiology | 2.13606118 |
| 26 | MP0004484_altered_response_of | 2.05716378 |
| 27 | MP0006138_congestive_heart_failure | 2.05543856 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.93072023 |
| 29 | MP0000747_muscle_weakness | 1.89440121 |
| 30 | MP0000759_abnormal_skeletal_muscle | 1.75099184 |
| 31 | MP0003123_paternal_imprinting | 1.74210096 |
| 32 | MP0004130_abnormal_muscle_cell | 1.73247037 |
| 33 | MP0005369_muscle_phenotype | 1.71303603 |
| 34 | MP0010630_abnormal_cardiac_muscle | 1.69061162 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.66838766 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.66573190 |
| 37 | MP0001661_extended_life_span | 1.65915981 |
| 38 | MP0004957_abnormal_blastocyst_morpholog | 1.65674953 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.64341044 |
| 40 | MP0004085_abnormal_heartbeat | 1.63887657 |
| 41 | MP0000350_abnormal_cell_proliferation | 1.54607908 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.52524116 |
| 43 | MP0005266_abnormal_metabolism | 1.52517104 |
| 44 | MP0009672_abnormal_birth_weight | 1.46747452 |
| 45 | MP0002796_impaired_skin_barrier | 1.43646392 |
| 46 | MP0005501_abnormal_skin_physiology | 1.43502592 |
| 47 | MP0003941_abnormal_skin_development | 1.42133318 |
| 48 | MP0004043_abnormal_pH_regulation | 1.38626565 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 1.38390687 |
| 50 | MP0004147_increased_porphyrin_level | 1.35766256 |
| 51 | MP0001529_abnormal_vocalization | 1.31713421 |
| 52 | MP0003315_abnormal_perineum_morphology | 1.26901073 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.23699249 |
| 54 | MP0003122_maternal_imprinting | 1.22624767 |
| 55 | MP0010030_abnormal_orbit_morphology | 1.21074379 |
| 56 | MP0001346_abnormal_lacrimal_gland | 1.19477094 |
| 57 | MP0002822_catalepsy | 1.19198689 |
| 58 | MP0000313_abnormal_cell_death | 1.19067275 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.17050138 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.11223248 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.09954646 |
| 62 | MP0003567_abnormal_fetal_cardiomyocyte | 1.09456768 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.09235429 |
| 64 | MP0001881_abnormal_mammary_gland | 1.07149117 |
| 65 | MP0003828_pulmonary_edema | 1.03360939 |
| 66 | MP0000358_abnormal_cell_content/ | 1.01962093 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 0.98398206 |
| 68 | MP0004858_abnormal_nervous_system | 0.98261653 |
| 69 | MP0005670_abnormal_white_adipose | 0.96278210 |
| 70 | MP0001730_embryonic_growth_arrest | 0.90536292 |
| 71 | MP0003111_abnormal_nucleus_morphology | 0.89179739 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.86931758 |
| 73 | MP0003077_abnormal_cell_cycle | 0.86923259 |
| 74 | MP0003186_abnormal_redox_activity | 0.86551251 |
| 75 | MP0009046_muscle_twitch | 0.86494381 |
| 76 | MP0002736_abnormal_nociception_after | 0.85646191 |
| 77 | MP0008932_abnormal_embryonic_tissue | 0.84111195 |
| 78 | MP0005408_hypopigmentation | 0.83968320 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.82697171 |
| 80 | MP0002085_abnormal_embryonic_tissue | 0.82249209 |
| 81 | MP0008260_abnormal_autophagy | 0.81753619 |
| 82 | MP0010094_abnormal_chromosome_stability | 0.81210270 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.80606053 |
| 84 | MP0009840_abnormal_foam_cell | 0.79891534 |
| 85 | MP0000537_abnormal_urethra_morphology | 0.79859999 |
| 86 | MP0000003_abnormal_adipose_tissue | 0.78199538 |
| 87 | MP0003879_abnormal_hair_cell | 0.76692015 |
| 88 | MP0000343_altered_response_to | 0.76628071 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.76399127 |
| 90 | MP0003984_embryonic_growth_retardation | 0.75767428 |
| 91 | MP0005332_abnormal_amino_acid | 0.75661013 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.74733535 |
| 93 | MP0001764_abnormal_homeostasis | 0.74382857 |
| 94 | MP0000266_abnormal_heart_morphology | 0.74360507 |
| 95 | MP0002909_abnormal_adrenal_gland | 0.73805910 |
| 96 | MP0003705_abnormal_hypodermis_morpholog | 0.73481541 |
| 97 | MP0002019_abnormal_tumor_incidence | 0.72820654 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.72576269 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.72466242 |
| 100 | MP0002735_abnormal_chemical_nociception | 0.72134974 |
| 101 | MP0003950_abnormal_plasma_membrane | 0.72024834 |
| 102 | MP0001727_abnormal_embryo_implantation | 0.71856286 |
| 103 | MP0002088_abnormal_embryonic_growth/wei | 0.70823394 |
| 104 | MP0002163_abnormal_gland_morphology | 0.70737003 |
| 105 | MP0004924_abnormal_behavior | 0.69923005 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.69923005 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.69032160 |
| 108 | MP0000733_abnormal_muscle_development | 0.68084395 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.67455782 |
| 110 | MP0000490_abnormal_crypts_of | 0.67434985 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.67405911 |
| 112 | MP0003878_abnormal_ear_physiology | 0.66888675 |
| 113 | MP0005377_hearing/vestibular/ear_phenot | 0.66888675 |
| 114 | MP0002086_abnormal_extraembryonic_tissu | 0.65294666 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.63729088 |
| 116 | MP0005165_increased_susceptibility_to | 0.63613494 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.62979235 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.62553568 |
| 119 | MP0005360_urolithiasis | 0.62342036 |
| 120 | MP0008058_abnormal_DNA_repair | 0.62013915 |
| 121 | MP0002970_abnormal_white_adipose | 0.60165826 |
| 122 | MP0005083_abnormal_biliary_tract | 0.59802380 |
| 123 | MP0003718_maternal_effect | 0.58756806 |
| 124 | MP0001756_abnormal_urination | 0.58176873 |
| 125 | MP0005380_embryogenesis_phenotype | 0.57852459 |
| 126 | MP0001672_abnormal_embryogenesis/_devel | 0.57852459 |
| 127 | MP0002080_prenatal_lethality | 0.57787104 |
| 128 | MP0001697_abnormal_embryo_size | 0.57723610 |
| 129 | MP0003121_genomic_imprinting | 0.56974789 |
| 130 | MP0001968_abnormal_touch/_nociception | 0.56422112 |
| 131 | MP0002078_abnormal_glucose_homeostasis | 0.53854212 |
| 132 | MP0008004_abnormal_stomach_pH | 0.53060168 |
| 133 | MP0003786_premature_aging | 0.52128831 |
| 134 | MP0004142_abnormal_muscle_tone | 0.51471343 |
| 135 | MP0002064_seizures | 0.51336799 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.49889655 |
| 137 | MP0009697_abnormal_copulation | 0.49742172 |
| 138 | MP0002272_abnormal_nervous_system | 0.49258265 |
| 139 | MP0008872_abnormal_physiological_respon | 0.48976611 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.48823181 |
| 141 | MP0002653_abnormal_ependyma_morphology | 0.46987853 |
| 142 | MP0005535_abnormal_body_temperature | 0.45915040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.44794984 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 5.39867519 |
| 3 | Hepatic necrosis (HP:0002605) | 5.03408951 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.98318374 |
| 5 | Sudden death (HP:0001699) | 4.82579704 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.73198770 |
| 7 | Increased serum pyruvate (HP:0003542) | 4.71073775 |
| 8 | Abnormality of glycolysis (HP:0004366) | 4.71073775 |
| 9 | Acute encephalopathy (HP:0006846) | 4.66148789 |
| 10 | Increased CSF lactate (HP:0002490) | 4.63232802 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 4.45698507 |
| 12 | Cholecystitis (HP:0001082) | 4.39360961 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 4.39360961 |
| 14 | Progressive macrocephaly (HP:0004481) | 4.37599839 |
| 15 | Exercise-induced myalgia (HP:0003738) | 4.27325254 |
| 16 | Palpitations (HP:0001962) | 4.24660173 |
| 17 | Myoglobinuria (HP:0002913) | 4.14611508 |
| 18 | Ventricular tachycardia (HP:0004756) | 4.11764750 |
| 19 | Nemaline bodies (HP:0003798) | 4.11277787 |
| 20 | Rhabdomyolysis (HP:0003201) | 3.90747241 |
| 21 | Lactic acidosis (HP:0003128) | 3.79545383 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.78296537 |
| 23 | Pheochromocytoma (HP:0002666) | 3.71436098 |
| 24 | Neuroendocrine neoplasm (HP:0100634) | 3.63589380 |
| 25 | Progressive muscle weakness (HP:0003323) | 3.61305945 |
| 26 | Exercise intolerance (HP:0003546) | 3.58776738 |
| 27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.51741994 |
| 28 | Respiratory failure (HP:0002878) | 3.49689329 |
| 29 | Increased serum lactate (HP:0002151) | 3.48202921 |
| 30 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.45607220 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 3.45607220 |
| 32 | Hyperalaninemia (HP:0003348) | 3.45607220 |
| 33 | Cerebral edema (HP:0002181) | 3.45279374 |
| 34 | Muscle fiber splitting (HP:0003555) | 3.37537970 |
| 35 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.35348411 |
| 36 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.35348411 |
| 37 | Myopathic facies (HP:0002058) | 3.33808401 |
| 38 | Atrial fibrillation (HP:0005110) | 3.31024767 |
| 39 | Ragged-red muscle fibers (HP:0003200) | 3.30240278 |
| 40 | Lipoatrophy (HP:0100578) | 3.29194947 |
| 41 | Microvesicular hepatic steatosis (HP:0001414) | 3.25975576 |
| 42 | Increased muscle lipid content (HP:0009058) | 3.25405317 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 3.24723870 |
| 44 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.23681002 |
| 45 | Supraventricular tachycardia (HP:0004755) | 3.16393392 |
| 46 | Conjunctival hamartoma (HP:0100780) | 3.14923779 |
| 47 | Primary atrial arrhythmia (HP:0001692) | 3.11743530 |
| 48 | Supraventricular arrhythmia (HP:0005115) | 3.08785399 |
| 49 | Increased intramyocellular lipid droplets (HP:0012240) | 3.05030510 |
| 50 | Neoplasm of the adrenal gland (HP:0100631) | 2.98763262 |
| 51 | Myotonia (HP:0002486) | 2.91496461 |
| 52 | CNS demyelination (HP:0007305) | 2.82699617 |
| 53 | Syncope (HP:0001279) | 2.81105448 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.75596246 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.75596246 |
| 56 | EMG: myopathic abnormalities (HP:0003458) | 2.74488371 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.74123884 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.73985975 |
| 59 | Subaortic stenosis (HP:0001682) | 2.73985975 |
| 60 | Right ventricular cardiomyopathy (HP:0011663) | 2.72184722 |
| 61 | Cholelithiasis (HP:0001081) | 2.71016068 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.68681204 |
| 63 | Ventricular fibrillation (HP:0001663) | 2.66315394 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.63432879 |
| 65 | Emotional lability (HP:0000712) | 2.60956362 |
| 66 | Ventricular arrhythmia (HP:0004308) | 2.59965189 |
| 67 | Bundle branch block (HP:0011710) | 2.59676162 |
| 68 | Testicular atrophy (HP:0000029) | 2.53733835 |
| 69 | Esophageal neoplasm (HP:0100751) | 2.52959654 |
| 70 | Neoplasm of head and neck (HP:0012288) | 2.52959654 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.44654998 |
| 72 | Prolonged QT interval (HP:0001657) | 2.42181939 |
| 73 | Increased connective tissue (HP:0009025) | 2.41657508 |
| 74 | Type I transferrin isoform profile (HP:0003642) | 2.41606824 |
| 75 | Gout (HP:0001997) | 2.41603271 |
| 76 | Muscle stiffness (HP:0003552) | 2.38083098 |
| 77 | Lethargy (HP:0001254) | 2.36687928 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34932631 |
| 79 | Increased hepatocellular lipid droplets (HP:0006565) | 2.33675250 |
| 80 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.33640500 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.33434932 |
| 82 | Optic disc pallor (HP:0000543) | 2.32728012 |
| 83 | Trismus (HP:0000211) | 2.31630718 |
| 84 | Ketoacidosis (HP:0001993) | 2.31180776 |
| 85 | Type 1 muscle fiber predominance (HP:0003803) | 2.30146108 |
| 86 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.29793702 |
| 87 | Cerebral hypomyelination (HP:0006808) | 2.26847571 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 2.26372440 |
| 89 | Leukodystrophy (HP:0002415) | 2.23492410 |
| 90 | Left ventricular hypertrophy (HP:0001712) | 2.23317590 |
| 91 | Athetosis (HP:0002305) | 2.23144833 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.21387660 |
| 93 | Reduced antithrombin III activity (HP:0001976) | 2.20305037 |
| 94 | Muscle fiber inclusion bodies (HP:0100299) | 2.17273113 |
| 95 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.15412622 |
| 96 | Hyperammonemia (HP:0001987) | 2.14793249 |
| 97 | Unsteady gait (HP:0002317) | 2.14666773 |
| 98 | Macrocytic anemia (HP:0001972) | 2.13858255 |
| 99 | Asymmetric septal hypertrophy (HP:0001670) | 2.13834161 |
| 100 | Truncus arteriosus (HP:0001660) | 2.10738443 |
| 101 | Nausea (HP:0002018) | 2.10086031 |
| 102 | Degeneration of anterior horn cells (HP:0002398) | 2.09914547 |
| 103 | Abnormality of the anterior horn cell (HP:0006802) | 2.09914547 |
| 104 | Oligomenorrhea (HP:0000876) | 2.09307778 |
| 105 | Reticulocytosis (HP:0001923) | 2.08274162 |
| 106 | Abnormality of reticulocytes (HP:0004312) | 2.07400501 |
| 107 | Multiple enchondromatosis (HP:0005701) | 2.06643526 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 2.05850886 |
| 109 | Reticulocytopenia (HP:0001896) | 2.05556105 |
| 110 | Hyperthyroidism (HP:0000836) | 2.04647766 |
| 111 | Abnormal EKG (HP:0003115) | 2.03859155 |
| 112 | Methylmalonic aciduria (HP:0012120) | 2.03709982 |
| 113 | Neck muscle weakness (HP:0000467) | 2.03641450 |
| 114 | Progressive external ophthalmoplegia (HP:0000590) | 2.02480751 |
| 115 | Abnormality of the vocal cords (HP:0008777) | 2.02440232 |
| 116 | Heart block (HP:0012722) | 2.02310651 |
| 117 | Hyperglycinuria (HP:0003108) | 2.01985952 |
| 118 | Hypokinesia (HP:0002375) | 2.01104884 |
| 119 | Respiratory difficulties (HP:0002880) | 2.00139509 |
| 120 | Tinnitus (HP:0000360) | 1.99812965 |
| 121 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.99375792 |
| 122 | Abnormality of the umbilical cord (HP:0010881) | 1.98456652 |
| 123 | Hypoglycemic coma (HP:0001325) | 1.98432545 |
| 124 | Gliosis (HP:0002171) | 1.98401447 |
| 125 | Difficulty climbing stairs (HP:0003551) | 1.97703140 |
| 126 | Distal lower limb amyotrophy (HP:0008944) | 1.96504430 |
| 127 | Areflexia of lower limbs (HP:0002522) | 1.96417055 |
| 128 | Adenoma sebaceum (HP:0009720) | 1.95164254 |
| 129 | Angiofibromas (HP:0010615) | 1.95164254 |
| 130 | Renal Fanconi syndrome (HP:0001994) | 1.94499813 |
| 131 | Atrioventricular block (HP:0001678) | 1.94292523 |
| 132 | Distal lower limb muscle weakness (HP:0009053) | 1.94048473 |
| 133 | Rimmed vacuoles (HP:0003805) | 1.91656410 |
| 134 | Calcaneovalgus deformity (HP:0001848) | 1.91373011 |
| 135 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91238502 |
| 136 | Rough bone trabeculation (HP:0100670) | 1.90507768 |
| 137 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89077833 |
| 138 | Aplastic anemia (HP:0001915) | 1.89020895 |
| 139 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87728670 |
| 140 | Abnormality of methionine metabolism (HP:0010901) | 1.87342143 |
| 141 | Abnormality of the tricuspid valve (HP:0001702) | 1.83603918 |
| 142 | Septate vagina (HP:0001153) | 1.82434677 |
| 143 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.77164583 |
| 144 | Abnormal protein glycosylation (HP:0012346) | 1.74005576 |
| 145 | Abnormal glycosylation (HP:0012345) | 1.74005576 |
| 146 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.74005576 |
| 147 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.74005576 |
| 148 | Deformed tarsal bones (HP:0008119) | 1.71384229 |
| 149 | Seborrheic dermatitis (HP:0001051) | 1.69348308 |
| 150 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.68277063 |
| 151 | Spastic paraparesis (HP:0002313) | 1.68206314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK1 | 4.36772766 |
| 2 | VRK2 | 4.26350145 |
| 3 | PDK3 | 3.97225087 |
| 4 | PDK4 | 3.97225087 |
| 5 | MYLK | 3.48101857 |
| 6 | BUB1 | 3.32789679 |
| 7 | TSSK6 | 3.09393570 |
| 8 | OBSCN | 3.01894560 |
| 9 | NME1 | 2.93048420 |
| 10 | TTN | 2.75317498 |
| 11 | PBK | 2.69434816 |
| 12 | BCKDK | 2.58891784 |
| 13 | SMG1 | 2.53766759 |
| 14 | LMTK2 | 2.52896746 |
| 15 | MAP3K12 | 2.40562991 |
| 16 | EIF2AK1 | 2.36063120 |
| 17 | PDK2 | 2.28687655 |
| 18 | CCNB1 | 2.23264734 |
| 19 | PHKG1 | 2.12033605 |
| 20 | PHKG2 | 2.12033605 |
| 21 | STK16 | 1.98242332 |
| 22 | EEF2K | 1.88524115 |
| 23 | IRAK3 | 1.66757521 |
| 24 | PKN2 | 1.54209560 |
| 25 | WEE1 | 1.52961387 |
| 26 | CASK | 1.49649774 |
| 27 | STK24 | 1.48694368 |
| 28 | DAPK1 | 1.40395042 |
| 29 | ARAF | 1.38373702 |
| 30 | LIMK1 | 1.37961713 |
| 31 | RPS6KB2 | 1.37532329 |
| 32 | TESK1 | 1.34073732 |
| 33 | AKT3 | 1.30818180 |
| 34 | TRIB3 | 1.30321857 |
| 35 | BRAF | 1.25646536 |
| 36 | STK38L | 1.20576658 |
| 37 | TESK2 | 1.19110353 |
| 38 | PINK1 | 1.18532275 |
| 39 | ILK | 1.15110296 |
| 40 | PIM2 | 1.10790872 |
| 41 | MAPKAPK3 | 1.10017403 |
| 42 | PLK2 | 1.09674811 |
| 43 | CDK7 | 1.08091114 |
| 44 | ICK | 1.05995466 |
| 45 | MST4 | 1.05768327 |
| 46 | MST1R | 1.02042019 |
| 47 | DAPK3 | 0.99442662 |
| 48 | SIK3 | 0.99316381 |
| 49 | MAP3K11 | 0.99094800 |
| 50 | KDR | 0.98504317 |
| 51 | NME2 | 0.96542756 |
| 52 | BRSK1 | 0.95044114 |
| 53 | MAP3K8 | 0.94739877 |
| 54 | CHEK2 | 0.88995692 |
| 55 | EIF2AK3 | 0.88819262 |
| 56 | ZAK | 0.87496006 |
| 57 | ATR | 0.86444232 |
| 58 | PIK3CA | 0.81920783 |
| 59 | LRRK2 | 0.80177552 |
| 60 | ERN1 | 0.78153885 |
| 61 | MAP2K7 | 0.75680886 |
| 62 | PLK3 | 0.75652071 |
| 63 | CDK19 | 0.74448300 |
| 64 | MAP3K4 | 0.70568279 |
| 65 | STK4 | 0.70567591 |
| 66 | MINK1 | 0.70183503 |
| 67 | SIK1 | 0.69666273 |
| 68 | CSNK1G3 | 0.69179070 |
| 69 | PAK4 | 0.69092039 |
| 70 | BRSK2 | 0.67550030 |
| 71 | CHEK1 | 0.67422575 |
| 72 | EPHA2 | 0.66596650 |
| 73 | PASK | 0.64238262 |
| 74 | AURKA | 0.64169134 |
| 75 | PLK1 | 0.64127096 |
| 76 | RAF1 | 0.64096235 |
| 77 | CAMK2D | 0.63050602 |
| 78 | MUSK | 0.60895761 |
| 79 | MAP3K5 | 0.60106502 |
| 80 | CDC7 | 0.59476147 |
| 81 | CSNK2A2 | 0.59227659 |
| 82 | TTK | 0.58986681 |
| 83 | CDK12 | 0.57657077 |
| 84 | ALK | 0.57256118 |
| 85 | PLK4 | 0.57229481 |
| 86 | TAF1 | 0.56180682 |
| 87 | PRKCI | 0.55936702 |
| 88 | WNK3 | 0.53960031 |
| 89 | MAPKAPK5 | 0.53764901 |
| 90 | MAP2K4 | 0.51169429 |
| 91 | TIE1 | 0.51093552 |
| 92 | KSR2 | 0.49470675 |
| 93 | ACVR1B | 0.47248866 |
| 94 | TAOK2 | 0.46043155 |
| 95 | ABL2 | 0.45551389 |
| 96 | PAK3 | 0.45198885 |
| 97 | MAP2K6 | 0.44456992 |
| 98 | CDK8 | 0.43619969 |
| 99 | ROCK1 | 0.42843922 |
| 100 | MAP2K1 | 0.42625181 |
| 101 | DMPK | 0.42118937 |
| 102 | CLK1 | 0.42045106 |
| 103 | PRKCG | 0.41295222 |
| 104 | MAP2K3 | 0.41217706 |
| 105 | CDK2 | 0.41091326 |
| 106 | CDK4 | 0.40999080 |
| 107 | AURKB | 0.40897200 |
| 108 | GRK7 | 0.40694860 |
| 109 | CAMK2G | 0.40611884 |
| 110 | RPS6KA4 | 0.40416266 |
| 111 | CDK18 | 0.40370215 |
| 112 | CSNK1A1L | 0.40268911 |
| 113 | PRKD3 | 0.40080817 |
| 114 | MAP3K3 | 0.40073309 |
| 115 | CDC42BPA | 0.40020852 |
| 116 | PAK1 | 0.39898164 |
| 117 | MAPK12 | 0.39723338 |
| 118 | SCYL2 | 0.38496210 |
| 119 | CDK1 | 0.38125602 |
| 120 | EIF2AK2 | 0.37648873 |
| 121 | VRK1 | 0.37434263 |
| 122 | SRPK1 | 0.36903115 |
| 123 | LATS2 | 0.36305472 |
| 124 | RPS6KC1 | 0.35344453 |
| 125 | RPS6KL1 | 0.35344453 |
| 126 | MAPK11 | 0.35198202 |
| 127 | CAMK2A | 0.34859629 |
| 128 | CDK14 | 0.34182914 |
| 129 | CSNK1G1 | 0.34122940 |
| 130 | AKT2 | 0.33056251 |
| 131 | CSNK1E | 0.31480518 |
| 132 | CDK15 | 0.31298782 |
| 133 | PRPF4B | 0.30830887 |
| 134 | ROCK2 | 0.29113041 |
| 135 | CSNK2A1 | 0.28622068 |
| 136 | CDK11A | 0.27243365 |
| 137 | RPS6KA6 | 0.26223507 |
| 138 | PRKACA | 0.26056512 |
| 139 | PRKAA1 | 0.25030580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 6.28446929 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.65731282 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.31966978 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 4.04279232 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.49643608 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.90112014 |
| 7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.80493105 |
| 8 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.72664434 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.67460344 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.52185020 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.29880833 |
| 12 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.27793188 |
| 13 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12600405 |
| 14 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.92032027 |
| 15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.79225378 |
| 16 | Sulfur relay system_Homo sapiens_hsa04122 | 1.70920975 |
| 17 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62233678 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.60847518 |
| 19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60767672 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55564751 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.53228329 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.48285961 |
| 23 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.45699756 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43499683 |
| 25 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.38930659 |
| 26 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.34221446 |
| 27 | Mismatch repair_Homo sapiens_hsa03430 | 1.25056503 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22408991 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.21694473 |
| 30 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18370286 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.16719226 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.11201896 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09736518 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05301464 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03863660 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99636165 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 0.97721508 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 0.96465941 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94021669 |
| 40 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92984496 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92415962 |
| 42 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92112804 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87078687 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.84857806 |
| 45 | Base excision repair_Homo sapiens_hsa03410 | 0.84616949 |
| 46 | Purine metabolism_Homo sapiens_hsa00230 | 0.84254930 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83840943 |
| 48 | Spliceosome_Homo sapiens_hsa03040 | 0.79203642 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77613599 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72143018 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69312435 |
| 52 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68892460 |
| 53 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68405036 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67372177 |
| 55 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65564047 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65185748 |
| 57 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62684999 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61664033 |
| 59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59259195 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.54821383 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54431218 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53960794 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53688657 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53124772 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52622748 |
| 66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50993394 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50889373 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49820241 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48369681 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44986242 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.44025064 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.42758108 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42496738 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42348297 |
| 75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40321833 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39620868 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38548147 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.38382597 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.34786780 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.32909738 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32735512 |
| 82 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32222549 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31098936 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.30209707 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.29902365 |
| 86 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29900708 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.29533476 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27837511 |
| 89 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27350300 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.24663818 |
| 91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24606366 |
| 92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23720485 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.22092379 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.21636481 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20835523 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20281174 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.19646517 |
| 98 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.18895660 |
| 99 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.18650177 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17977311 |
| 101 | Basal transcription factors_Homo sapiens_hsa03022 | 0.17736722 |
| 102 | Protein export_Homo sapiens_hsa03060 | 0.17626868 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.17336145 |
| 104 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17298459 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16306378 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14791808 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.14344640 |
| 108 | Tight junction_Homo sapiens_hsa04530 | 0.14297048 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13803288 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.12784471 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.12756978 |
| 112 | Legionellosis_Homo sapiens_hsa05134 | 0.12711971 |
| 113 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11846497 |
| 114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.11321545 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10805943 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.10733384 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.10057044 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.09592275 |
| 119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.08432386 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08141117 |
| 121 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.05664168 |

